English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    I. A. Kachailo, I. A. Guz, O. О. Kuzmina

    STATE OF THE HORMONAL PROFILE IN ENDOMETRIAL HYPERPLASIA


    About the author: I. A. Kachailo, I. A. Guz, O. О. Kuzmina
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The research data of 93 patients were analyzed. Patients were divided into three clinical groups depending on the form of endometrial hyperplasia: group 1: with uncomplicated non-atypical endometrial hyperplasia – 53 patients; group 2: with complex non-atypical endometrial hyperplasia – 22 patients; group 3: with simple atypical endometrial hyperplasia – 18 patients. The control group consisted of 20 healthy women. Comparative analysis showed that the level of hormones in the 1st phase of the menstrual cycle was not significantly different between the groups for most indices of luteinizing hormone in group 2 compared to groups 1 and 3 (p < 0.01). The study of hormonal status in women of 3 clinical groups showed that, compared to the control group, there was a significantly greater increase in the level of testosterone in blood plasma (p < 0.05). Progesterone content in the control group was lower (almost by 5 times) than the control level (p < 0.001). The estradiol level in groups 1 and 2 decreased and was three times lower compared to the control group (p < 0.001). With simple atypical EH, the concentration of estradiol was sharply increased compared to the control groups, 1 and 2, which confirms the stimulation of the proliferative processes’ development in the endometrium.
    Tags endometrial hyperplasia,morphological features,hormonal status
    Bibliography
    • Benyuk VO, Honcharenko V.M, Kravchenko Yu.V. Suchasnyy alhorytm diahnostyky hiperplastychnykh protsesiv. Zbirnyk naukovykh prats Asotsiatsiyi akusheriv–hinekolohiv Ukrayiny. 2018;2(42):25–29. [in Ukrainian]
    • Boychuk AV, Shadrina VS, Vereshchahina TV. Hiperplaziya endometriya – suchasnyy systemno-patohenetychnyy pohlyad na problemu (ohlyad literatury). Aktualni pytannya pediatriyi, akusherstva ta hinekolohiyi. 2019; 1. С. 67–72. [in Ukrainian]
    • Horban NYE. Suchasnyy pohlyad na problemu protsesiv v endometriyi (ohlyad literatury). Visnyk naukovykh doslidzhen. 2018; 1, 39–44. https://doi.org/10.11603/2415-8798.2018.1.8741 [in Ukrainian]
    • Makarenko MV, Hovseyev DO, Hridchyn SV. Alhorytm diahnostyky dobroyakisnykh zakhvoryuvan matky na osnovi danykh imunohistolohichnoho analizu. Zdorovye zhenshchyny.2016;1(107):50–52. [in Ukrainian]
    • Khaskhachykh DA, Potapov VO. Vplyv ekspresiyi retseptoriv estroheniv ta prohesteronu na efektyvnist likuvannya hiperplaziyi endometriya bez atypiyi. Zbirnyk naukovykh prats Asotsiatsiyi akusheriv-hinekolohiv Ukrayiny.2018;2(42):203–207. [in Ukrainian]
    • Auclair MH, Yong PJ, Salvador S, Thurston J, Colgan TTJ, Sebastianelli A. Guideline No. 390-Classification and Management of Endometrial Hyperplasia. J Obstet Gynaecol Can. 2019 Dec;41(12):1789–1800. doi: 10.1016/j.jogc.2019.03.025.
    • Doherty MT, Sanni OB, Coleman HG, Cardwell CR, McCluggage WG, Quinn D, et al. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis. PLoS One. 2020 Apr 28;15(4): e0232231. doi: 10.1371/journal.pone.0232231.
    • Gil González Y, Pérez Morales ME, Emergi Zhrigen Y, Santana Suárez MA, Pérez Matos C, Nieto Naya MÁ, et al. Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy. J Obstet Gynaecol. 2022 Nov;42(8):3435–3440. doi: 10.1080/01443615.2022.2152656.
    • Laban M, El-Swaify ST, Ali SH, Refaat MA, Sabbour M, Farrag N. Preoperative detection of occult endometrial malignancies in endometrial hyperplasia to improve primary surgical therapy: A scoping review of the literature. Int J Gynaecol Obstet. 2022 Oct;159(1):21–42. doi: 10.1002/ijgo.14139.
    • Li M, Song JL, Zhao Y, Wu SL, Liu HB, Tang R, Yan L. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization. J Zhejiang Univ Sci B. 2017 Nov.;18(11):1022–1025. doi: 10.1631/jzus.B1600523.
    • Lytvynenko OV, Hromova AМ, Nesterenko LA, Martynenko VB, Liakhovska TYu. Peculiarities of postoperative period in women with uterine leiomyoma after uterine artery embolization. World of Medicine and Biology. 2019. 3(69), 105–108 doi:10.26724/2079-8334-2019-3-69-105-108.
    • Raffone A, Travaglino A, Saccone G, Di Maio A, Mollo A, Mascolo M, et al. Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecol Endocrinol. 2019 Nov;35(11):932–937. doi: 10.1080/09513590.2019.1624716.
    • Sobczuk K, Sobczuk A. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Prz Menopauzalny. 2017 Sep;16(3):107–111. doi: 10.5114/pm.2017.70589.
    • Zhang M, Zhang T, Song C, Qu J, Gu Y, Liu S, et al. Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis. J Ethnopharmacol. 2021 Jun 28; 274:114064. doi: 10.1016/j.jep.2021.114064.
    Publication of the article «World of Medicine and Biology» №4(86), 2023 year, 069-073 pages, index UDK 61814-06:618.173]-018:616-006]-07
    DOI 10.26724/2079-8334-2023-4-86-69-73